BioCentury
ARTICLE | Company News

Regulus management update

July 1, 2013 7:00 AM UTC

Regulus Therapeutics Inc. (NASDAQ:RGLS), San Diego, Calif. Business: Infectious, Cancer, Cardiovascular Resigned: Garry Menzel as COO and EVP of finance Transitioned: Kleanthis Xanthopoulos to princip...